Back to Journals » OncoTargets and Therapy » Volume 7

Development of anaplastic lymphoma kinase (ALK) inhibitors and molecular diagnosis in ALK rearrangement-positive lung cancer

Total article views   HTML views PDF downloads Totals
16,154 Dovepress* 12,670+ 3,421 16,091
PubMed Central* 3,484 1,162 4,646
Totals 16,154 4,583 20,737
*Since 5 March 2014
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar